Dr Robert Perry wrote to Michael Palmer providing Background Notes on the Development of Hepatitis-Safe Factor VIII Concentrate by SNBTS. Read more about Dr Robert Perry wrote to Michael Palmer providing Background Notes on the Development of Hepatitis-Safe Factor VIII Concentrate by SNBTS.
Michael Palmer wrote to the SNBTS National Director regarding the investigation of circumstances surrounding the safety of SNBTS blood products from Hepatitis C. Read more about Michael Palmer wrote to the SNBTS National Director regarding the investigation of circumstances surrounding the safety of SNBTS blood products from Hepatitis C.
Background Notes on the Development of Hepatitis-Safe Factor 8 concentrates were produced by SNBTS. Read more about Background Notes on the Development of Hepatitis-Safe Factor 8 concentrates were produced by SNBTS.
Fax from Jane Kelly of PFC to Mike Palmer at the Department of Health, Scottish Office, including a document titled Factor VIII Concentrates manufactured by SNBTS (1974-1999). Read more about Fax from Jane Kelly of PFC to Mike Palmer at the Department of Health, Scottish Office, including a document titled Factor VIII Concentrates manufactured by SNBTS (1974-1999).
Michael Palmer, Dr Keel, Lynda Towers and Sandra Falconer met Professor Ian Franklin of SNBTS and Drs Robert Perry and Ron McIntosh of PFC to discuss the investigation of circumstances surrounding the safety of SNBTS blood products from Hepatitis C. Read more about Michael Palmer, Dr Keel, Lynda Towers and Sandra Falconer met Professor Ian Franklin of SNBTS and Drs Robert Perry and Ron McIntosh of PFC to discuss the investigation of circumstances surrounding the safety of SNBTS blood products from Hepatitis C.
Susan Deacon's office advised that discussions around compensation were very much a PR exercise and it was unlikely to ever be paid. In her oral evidence, Susan Deacon refuted using these words herself. Read more about Susan Deacon's office advised that discussions around compensation were very much a PR exercise and it was unlikely to ever be paid. In her oral evidence, Susan Deacon refuted using these words herself.
Susan Deacon told the Inquiry how at this point she had to examine properly what had happened in the 1980s around heat treatment and wished to set out the facts "as best we could in the public domain." Read more about Susan Deacon told the Inquiry how at this point she had to examine properly what had happened in the 1980s around heat treatment and wished to set out the facts "as best we could in the public domain."
Michael Palmer informed Susan Deacon, that officials had already written to SNBTS, Department of Health and haemophilia clinicians in Scotland requesting detailed information on events raised by Margaret Smith MSP on 6 August 1999, and provided a draft reply from the Minister to Margaret Smith MSP. Read more about Michael Palmer informed Susan Deacon, that officials had already written to SNBTS, Department of Health and haemophilia clinicians in Scotland requesting detailed information on events raised by Margaret Smith MSP on 6 August 1999, and provided a draft reply from the Minister to Margaret Smith MSP.
Margaret Smith MSP, convener of the Health and Community Care Committee, wrote to Susan Deacon calling for an immediate Executive Inquiry to allay public fear and concerns about the safety of Scottish blood products. Read more about Margaret Smith MSP, convener of the Health and Community Care Committee, wrote to Susan Deacon calling for an immediate Executive Inquiry to allay public fear and concerns about the safety of Scottish blood products.
In a press release from the Haemophilia Society, Philip Dolan, speaking on behalf of Scottish members, appealed to the Scottish Parliament "who could decide to act now for Scottish people with haemophilia and HCV." Read more about In a press release from the Haemophilia Society, Philip Dolan, speaking on behalf of Scottish members, appealed to the Scottish Parliament "who could decide to act now for Scottish people with haemophilia and HCV."